Novel selective inhibitors applicable in viral replication, cancer and inflammation

Technology offer: Novel selective inhibitors applicable in viral replication, cancer and inflammation

Reference: TOIT20140414003

Summary: An Italian highly innovative company with business unit in the USA, has developed a robust pipeline of novel, proprietary, selective inhibitors for a number of distinct disease indications.

The company is seeking to leverage its internal programs through licensing collaborations or technological agreements.

For more information click here.

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.